Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MEDICINOVA INCMNOV · Entity 7011 | Chief Scientific Officer | April 22, 2021 | April 27, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MEDICINOVA INC
Report date April 22, 2021 · Filed April 27, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.56 · Expires 2031-04-22 | Direct | 24,000 |
Reported balance
After 2021-04-22 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2021-04-22 · Grant · Acquired 24,000 · Balance 24,000 F1: The option vests in equal monthly installments over a period of three (3) years commencing April 22, 2021, subject to continued service with the Company. |
Filing footnotes · ownership attribution and instrument terms
F1: The option vests in equal monthly installments over a period of three (3) years commencing April 22, 2021, subject to continued service with the Company.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 22, 2021 Filed Apr 27, 2021 00:25 UTC | MEDICINOVA INC MNOV · Entity 7011 | GrantEmployee Stock Option (Right to Buy) · Derivative | 24,000 | $0.00 Strike: $4.56 | $0.00 |
DisclosureSEC source: 0001683168-21-001543 · ownership.xml · derivative · entry 1 Gaeta Federico C.A. · CIK 0001859057 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,000 Underlying: Common Stock · 24,000 shares Expires 2031-04-22 F1 · derivative.exercise_date: The option vests in equal monthly installments over a period of three (3) years commencing April 22, 2021, subject to continued service with the Company. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.